| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | CTP synthase activity | 6.82e-07 | 2 | 17 | 2 | GO:0003883 | |
| GeneOntologyMolecularFunction | aspartic endopeptidase activity, intramembrane cleaving | 1.90e-05 | 8 | 17 | 2 | GO:0042500 | |
| GeneOntologyMolecularFunction | sodium ion binding | 6.17e-05 | 14 | 17 | 2 | GO:0031402 | |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 2.19e-04 | 26 | 17 | 2 | GO:0005248 | |
| GeneOntologyMolecularFunction | alkali metal ion binding | 2.19e-04 | 26 | 17 | 2 | GO:0031420 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 3.84e-04 | 171 | 17 | 3 | GO:0015081 | |
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 4.46e-04 | 37 | 17 | 2 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 4.71e-04 | 38 | 17 | 2 | GO:0070001 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 5.17e-04 | 459 | 17 | 4 | GO:0005216 | |
| GeneOntologyMolecularFunction | channel activity | 8.56e-04 | 525 | 17 | 4 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 8.62e-04 | 526 | 17 | 4 | GO:0022803 | |
| GeneOntologyMolecularFunction | sodium channel activity | 8.82e-04 | 52 | 17 | 2 | GO:0005272 | |
| GeneOntologyMolecularFunction | ligase activity, forming carbon-nitrogen bonds | 9.16e-04 | 53 | 17 | 2 | GO:0016879 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | 2.04e-03 | 664 | 17 | 4 | GO:0008324 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 2.86e-03 | 343 | 17 | 3 | GO:0005261 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | 3.88e-03 | 793 | 17 | 4 | GO:0015075 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 6.69e-03 | 465 | 17 | 3 | GO:0046873 | |
| GeneOntologyMolecularFunction | ligase activity | 9.42e-03 | 174 | 17 | 2 | GO:0016874 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 1.51e-02 | 627 | 17 | 3 | GO:0022890 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | 1.55e-02 | 1180 | 17 | 4 | GO:0022857 | |
| GeneOntologyBiologicalProcess | 'de novo' CTP biosynthetic process | 6.39e-07 | 2 | 17 | 2 | GO:0044210 | |
| GeneOntologyBiologicalProcess | pyrimidine nucleobase biosynthetic process | 1.79e-05 | 8 | 17 | 2 | GO:0019856 | |
| GeneOntologyBiologicalProcess | CTP biosynthetic process | 6.67e-05 | 15 | 17 | 2 | GO:0006241 | |
| GeneOntologyBiologicalProcess | pyrimidine ribonucleoside triphosphate biosynthetic process | 7.62e-05 | 16 | 17 | 2 | GO:0009209 | |
| GeneOntologyBiologicalProcess | CTP metabolic process | 8.63e-05 | 17 | 17 | 2 | GO:0046036 | |
| GeneOntologyBiologicalProcess | nucleobase biosynthetic process | 9.71e-05 | 18 | 17 | 2 | GO:0046112 | |
| GeneOntologyBiologicalProcess | pyrimidine ribonucleoside triphosphate metabolic process | 1.08e-04 | 19 | 17 | 2 | GO:0009208 | |
| GeneOntologyBiologicalProcess | pyrimidine nucleoside triphosphate biosynthetic process | 1.20e-04 | 20 | 17 | 2 | GO:0009148 | |
| GeneOntologyBiologicalProcess | pyrimidine nucleobase metabolic process | 1.46e-04 | 22 | 17 | 2 | GO:0006206 | |
| GeneOntologyBiologicalProcess | pyrimidine ribonucleotide biosynthetic process | 1.90e-04 | 25 | 17 | 2 | GO:0009220 | |
| GeneOntologyBiologicalProcess | pyrimidine nucleoside triphosphate metabolic process | 1.90e-04 | 25 | 17 | 2 | GO:0009147 | |
| GeneOntologyBiologicalProcess | glutamine metabolic process | 2.74e-04 | 30 | 17 | 2 | GO:0006541 | |
| GeneOntologyBiologicalProcess | pyrimidine nucleotide biosynthetic process | 3.33e-04 | 33 | 17 | 2 | GO:0006221 | |
| GeneOntologyBiologicalProcess | pyrimidine ribonucleotide metabolic process | 3.53e-04 | 34 | 17 | 2 | GO:0009218 | |
| GeneOntologyBiologicalProcess | membrane depolarization during action potential | 3.96e-04 | 36 | 17 | 2 | GO:0086010 | |
| GeneOntologyBiologicalProcess | pyrimidine-containing compound biosynthetic process | 5.66e-04 | 43 | 17 | 2 | GO:0072528 | |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | 6.19e-04 | 208 | 17 | 3 | GO:0035725 | |
| GeneOntologyBiologicalProcess | nucleobase metabolic process | 6.20e-04 | 45 | 17 | 2 | GO:0009112 | |
| GeneOntologyBiologicalProcess | membrane protein ectodomain proteolysis | 8.60e-04 | 53 | 17 | 2 | GO:0006509 | |
| GeneOntologyBiologicalProcess | calcineurin-NFAT signaling cascade | 8.92e-04 | 54 | 17 | 2 | GO:0033173 | |
| GeneOntologyBiologicalProcess | pyrimidine nucleotide metabolic process | 9.25e-04 | 55 | 17 | 2 | GO:0006220 | |
| GeneOntologyBiologicalProcess | calcineurin-mediated signaling | 1.03e-03 | 58 | 17 | 2 | GO:0097720 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential involved in contraction | 1.17e-03 | 62 | 17 | 2 | GO:0086002 | |
| GeneOntologyBiologicalProcess | neuronal action potential | 1.21e-03 | 63 | 17 | 2 | GO:0019228 | |
| GeneOntologyBiologicalProcess | membrane protein proteolysis | 1.25e-03 | 64 | 17 | 2 | GO:0033619 | |
| GeneOntologyBiologicalProcess | sodium ion transport | 1.39e-03 | 275 | 17 | 3 | GO:0006814 | |
| GeneOntologyBiologicalProcess | T cell proliferation | 1.58e-03 | 288 | 17 | 3 | GO:0042098 | |
| GeneOntologyBiologicalProcess | detection of mechanical stimulus | 1.71e-03 | 75 | 17 | 2 | GO:0050982 | |
| GeneOntologyBiologicalProcess | glutamine family amino acid metabolic process | 1.95e-03 | 80 | 17 | 2 | GO:0009064 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential | 2.30e-03 | 87 | 17 | 2 | GO:0086001 | |
| GeneOntologyBiologicalProcess | pyrimidine-containing compound metabolic process | 2.56e-03 | 92 | 17 | 2 | GO:0072527 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell contraction | 2.62e-03 | 93 | 17 | 2 | GO:0086003 | |
| GeneOntologyCellularComponent | cytoophidium | 1.87e-06 | 3 | 17 | 2 | GO:0097268 | |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 8.41e-05 | 17 | 17 | 2 | GO:0001518 | |
| GeneOntologyCellularComponent | sodium channel complex | 2.49e-04 | 29 | 17 | 2 | GO:0034706 | |
| Domain | CTP_synthase_N | 7.80e-07 | 2 | 17 | 2 | IPR017456 | |
| Domain | GATase1_CTP_Synthase | 7.80e-07 | 2 | 17 | 2 | IPR033828 | |
| Domain | CTP_synth_N | 7.80e-07 | 2 | 17 | 2 | PF06418 | |
| Domain | CTP_synthase | 7.80e-07 | 2 | 17 | 2 | IPR004468 | |
| Domain | GATase | 7.79e-06 | 5 | 17 | 2 | PF00117 | |
| Domain | GATASE | 1.17e-05 | 6 | 17 | 2 | IPR017926 | |
| Domain | Na_trans_cytopl | 1.17e-05 | 6 | 17 | 2 | PF11933 | |
| Domain | GATASE_TYPE_1 | 1.17e-05 | 6 | 17 | 2 | PS51273 | |
| Domain | Na_trans_cytopl | 1.17e-05 | 6 | 17 | 2 | IPR024583 | |
| Domain | Na_channel_asu | 3.49e-05 | 10 | 17 | 2 | IPR001696 | |
| Domain | Na_trans_assoc | 3.49e-05 | 10 | 17 | 2 | IPR010526 | |
| Domain | Na_trans_assoc | 3.49e-05 | 10 | 17 | 2 | PF06512 | |
| Domain | - | 3.49e-05 | 10 | 17 | 2 | 3.40.50.880 | |
| Domain | Class_I_gatase-like | 5.12e-05 | 12 | 17 | 2 | IPR029062 | |
| Domain | Ion_trans_dom | 1.41e-04 | 114 | 17 | 3 | IPR005821 | |
| Domain | Ion_trans | 1.41e-04 | 114 | 17 | 3 | PF00520 | |
| Domain | Channel_four-helix_dom | 1.21e-03 | 57 | 17 | 2 | IPR027359 | |
| Domain | - | 1.21e-03 | 57 | 17 | 2 | 1.20.120.350 | |
| Domain | IQ | 1.87e-03 | 71 | 17 | 2 | PF00612 | |
| Domain | IQ | 2.42e-03 | 81 | 17 | 2 | SM00015 | |
| Domain | IQ_motif_EF-hand-BS | 2.98e-03 | 90 | 17 | 2 | IPR000048 | |
| Domain | IQ | 3.18e-03 | 93 | 17 | 2 | PS50096 | |
| Domain | EF-hand-dom_pair | 2.75e-02 | 287 | 17 | 2 | IPR011992 | |
| Pathway | WP_DRAVET_SYNDROME_SCN1AA1783V_POINT_MUTATION_MODEL | 2.83e-05 | 73 | 12 | 3 | MM16641 | |
| Pathway | WP_DRAVET_SYNDROME | 2.48e-04 | 28 | 12 | 2 | M45519 | |
| Pathway | REACTOME_INTERCONVERSION_OF_NUCLEOTIDE_DI_AND_TRIPHOSPHATES | 2.66e-04 | 29 | 12 | 2 | MM15158 | |
| Pathway | REACTOME_INTERCONVERSION_OF_NUCLEOTIDE_DI_AND_TRIPHOSPHATES | 2.66e-04 | 29 | 12 | 2 | M27408 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 3.05e-04 | 31 | 12 | 2 | M877 | |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 3.25e-04 | 32 | 12 | 2 | M27455 | |
| Pathway | WP_PYRIMIDINE_METABOLISM | 2.23e-03 | 84 | 12 | 2 | M48340 | |
| Pathway | REACTOME_METABOLISM_OF_NUCLEOTIDES | 2.96e-03 | 97 | 12 | 2 | MM14607 | |
| Pathway | REACTOME_METABOLISM_OF_NUCLEOTIDES | 2.96e-03 | 97 | 12 | 2 | M777 | |
| Pathway | KEGG_PYRIMIDINE_METABOLISM | 3.02e-03 | 98 | 12 | 2 | M5109 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 4.56e-03 | 121 | 12 | 2 | M872 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 5.24e-03 | 130 | 12 | 2 | M27454 | |
| Pubmed | Correlations in timing of sodium channel expression, epilepsy, and sudden death in Dravet syndrome. | 2.25e-07 | 2 | 17 | 2 | 23965409 | |
| Pubmed | Electrophysiological Differences between the Same Pore Region Mutation in SCN1A and SCN3A. | 2.25e-07 | 2 | 17 | 2 | 24990319 | |
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 27690330 | ||
| Pubmed | Regulation of human cytidine triphosphate synthetase 2 by phosphorylation. | 2.25e-07 | 2 | 17 | 2 | 20739275 | |
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 23859570 | ||
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 14973256 | ||
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 18784617 | ||
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 12610651 | ||
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 17544618 | ||
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 16179339 | ||
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 33895391 | ||
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 27816501 | ||
| Pubmed | 1.35e-06 | 4 | 17 | 2 | 17537961 | ||
| Pubmed | 1.35e-06 | 4 | 17 | 2 | 35031483 | ||
| Pubmed | 1.35e-06 | 4 | 17 | 2 | 35801810 | ||
| Pubmed | 1.35e-06 | 4 | 17 | 2 | 29578003 | ||
| Pubmed | Use of recombinant inbred strains for studying genetic determinants of responses to alcohol. | 1.35e-06 | 4 | 17 | 2 | 8974318 | |
| Pubmed | 2.25e-06 | 5 | 17 | 2 | 1679748 | ||
| Pubmed | 2.25e-06 | 5 | 17 | 2 | 8812438 | ||
| Pubmed | 2.25e-06 | 5 | 17 | 2 | 24337656 | ||
| Pubmed | Inactivation of cytidine triphosphate synthase 1 prevents fatal auto-immunity in mice. | 3.37e-06 | 6 | 17 | 2 | 38438357 | |
| Pubmed | A 'toothache tree' alkylamide inhibits Aδ mechanonociceptors to alleviate mechanical pain. | 3.37e-06 | 6 | 17 | 2 | 23652591 | |
| Pubmed | 4.25e-06 | 529 | 17 | 5 | 14621295 | ||
| Pubmed | 8.08e-06 | 9 | 17 | 2 | 16382098 | ||
| Pubmed | 8.08e-06 | 9 | 17 | 2 | 15746173 | ||
| Pubmed | CTPS and IMPDH form cytoophidia in developmental thymocytes. | 1.01e-05 | 10 | 17 | 2 | 34022203 | |
| Pubmed | Nav1.2 haplodeficiency in excitatory neurons causes absence-like seizures in mice. | 1.48e-05 | 12 | 17 | 2 | 30175250 | |
| Pubmed | 1.48e-05 | 12 | 17 | 2 | 8169823 | ||
| Pubmed | 1.75e-05 | 13 | 17 | 2 | 15123669 | ||
| Pubmed | Confirmation of quantitative trait loci for alcohol preference in mice. | 2.35e-05 | 15 | 17 | 2 | 9726281 | |
| Pubmed | 1.35e-04 | 208 | 17 | 3 | 22145905 | ||
| Pubmed | HAPSTR1 localizes HUWE1 to the nucleus to limit stress signaling pathways. | 1.44e-04 | 571 | 17 | 4 | 37167062 | |
| Pubmed | 1.49e-04 | 215 | 17 | 3 | 30462309 | ||
| Pubmed | 1.76e-04 | 1153 | 17 | 5 | 29845934 | ||
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | 3.21e-04 | 704 | 17 | 4 | 29955894 | |
| Pubmed | Interactomic analysis reveals a homeostatic role for the HIV restriction factor TRIM5α in mitophagy. | 3.65e-04 | 292 | 17 | 3 | 35545034 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | 3.70e-04 | 1353 | 17 | 5 | 29467282 | |
| Interaction | CACNA1B interactions | 3.81e-06 | 37 | 17 | 3 | int:CACNA1B | |
| Interaction | ASCL1 interactions | 6.92e-06 | 45 | 17 | 3 | int:ASCL1 | |
| Interaction | CYP27C1 interactions | 1.00e-05 | 6 | 17 | 2 | int:CYP27C1 | |
| Interaction | CTPS1 interactions | 5.00e-05 | 252 | 17 | 4 | int:CTPS1 | |
| Interaction | TIGD3 interactions | 5.20e-05 | 13 | 17 | 2 | int:TIGD3 | |
| Interaction | F8A1 interactions | 5.20e-05 | 13 | 17 | 2 | int:F8A1 | |
| Interaction | TLR7 interactions | 6.99e-05 | 15 | 17 | 2 | int:TLR7 | |
| Interaction | TRMT6 interactions | 8.37e-05 | 103 | 17 | 3 | int:TRMT6 | |
| Interaction | CTPS2 interactions | 1.71e-04 | 131 | 17 | 3 | int:CTPS2 | |
| Interaction | RNASEH2C interactions | 1.83e-04 | 24 | 17 | 2 | int:RNASEH2C | |
| Interaction | RAB28 interactions | 1.83e-04 | 24 | 17 | 2 | int:RAB28 | |
| Interaction | NHLRC1 interactions | 1.99e-04 | 25 | 17 | 2 | int:NHLRC1 | |
| Interaction | CMIP interactions | 2.87e-04 | 30 | 17 | 2 | int:CMIP | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q24 | 1.00e-03 | 127 | 17 | 2 | chr2q24 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12p13 | 7.43e-03 | 353 | 17 | 2 | chr12p13 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 1.21e-05 | 9 | 11 | 2 | 1203 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma-4|TCGA-Breast / Sample_Type by Project: Shred V9 | 3.97e-05 | 178 | 17 | 3 | 44b5ba4e8788d3973749a1717e427647ac4c8579 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.53e-05 | 186 | 17 | 3 | acfa68a2afb7d2b51c9b469a1965fe5cc5d5e64e | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.13e-05 | 194 | 17 | 3 | 04bfc555743f7d8821439d05ae442d15e9886c59 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.13e-05 | 194 | 17 | 3 | 69bff17df4a760ccf081cf52ff04af02c14f448d | |
| Computational | Neighborhood of RFC3 | 5.02e-04 | 41 | 9 | 2 | GNF2_RFC3 | |
| Computational | Neighborhood of RFC4 | 1.08e-03 | 60 | 9 | 2 | GNF2_RFC4 | |
| Computational | Neighborhood of RAN | 2.20e-03 | 86 | 9 | 2 | GNF2_RAN | |
| Drug | gamma-glutamylhydroxamate | 1.88e-05 | 9 | 17 | 2 | CID000159636 | |
| Drug | arginine hydroxamate | 2.35e-05 | 10 | 17 | 2 | CID000151275 | |
| Drug | bacilysin | 5.48e-05 | 15 | 17 | 2 | CID000160175 | |
| Drug | Zonisamide | 7.09e-05 | 17 | 17 | 2 | DB00909 | |
| Drug | cyclopentenyl cytosine | 8.91e-05 | 19 | 17 | 2 | CID000072828 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 1.40e-05 | 10 | 17 | 2 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 1.40e-05 | 10 | 17 | 2 | DOID:0080422 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 2.05e-05 | 12 | 17 | 2 | DOID:0060170 (implicated_via_orthology) | |
| Disease | anxiety disorder (implicated_via_orthology) | 7.17e-05 | 22 | 17 | 2 | DOID:2030 (implicated_via_orthology) | |
| Disease | Autism Spectrum Disorders | 1.08e-03 | 85 | 17 | 2 | C1510586 | |
| Disease | epilepsy (implicated_via_orthology) | 3.91e-03 | 163 | 17 | 2 | DOID:1826 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DVQRFFQVVSFMVDA | 661 | O60241 | |
| QVYFRIVTMDSNFVP | 136 | A8K2U0 | |
| LPRNVMFVFFQGETF | 321 | Q92542 | |
| TVVAFFIMPARTNNF | 361 | P13807 | |
| RIFTPVVFFTTAFDM | 81 | Q4G0N8 | |
| SMPFIEAFRQFQFKV | 156 | P17812 | |
| QGMVFDFVTRQVFDI | 1516 | Q9NY46 | |
| QGMVFDFVTRQVFDI | 1531 | P35498 | |
| VIEFFVMVFQFGVPQ | 656 | Q15021 | |
| GMPFVEAFRQFQFKA | 156 | Q9NRF8 | |
| YFQRVPINESFISMV | 211 | Q12768 | |
| IMERNFQPVIIFSFS | 381 | P42285 | |
| VMFFFFDSVQVVFTI | 86 | Q8TCT6 | |
| FFILPAVTERMFNQN | 2046 | Q92508 | |
| VMATQAFVLFQFPFT | 226 | Q12836 | |
| VATYVFVEFFVNPMR | 196 | Q8WTX9 | |
| PQDFRNFVTMFVVFV | 231 | P48039 |